Bardy Diagnostics, maker of an adhesive ambulatory cardiac patch for remote monitoring, has raised $35.5 million in a Series B funding round led by River Cities Capital Funds. The round also featured participation from newcomers HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures and Rex Health Ventures, as well as returning backers SV Health Investors, Health...
Nearly a year after announcing its direct-to-consumer fitness tracker AmpStrip -- and after raising more than $500,000 on Indiegogo for it -- Fitlinxx has announced that it will not be developing AmpStrip as a fitness tracker, but rather as a medical device. The company will refund all of its nearly 4,000 backers on request. Engadget first reported the news.
The news came in an update to the...
